Research Advances in Fenofibrate Single Usage and Acid with Statin Drug Combinations in Controlling High Fat

Cardiovascular disease(CVD) is the leading cause of mortality worldwide.Lifestyle modifications,along with low-density lipoprotein cholesterol(LDL-C) reduction,remain the highest priorities in CVD risk management.For LDL-C reduction,statins are the most effective and have demonstrated incremental benefits in CVD risk reduction.However,there is a need for additional measures.Fenofibric acid is the newest available option.It not only overcomes the drawbacks of older fibrates,particularly in terms of pharmacokinetic properties,but it has also been shown to be the most suitable fibrate to combine with a statin.